Biocytogen Pharmaceuticals and Pheon Therapeutics Announced a License Agreement

Biocytogen Pharmaceuticals announced a licence agreement with Pheon Therapeutics regarding the development and commercialisation of an antibody. Under the terms of the agreement, Pheon will develop and commercialise an antibody developed on Biocytogen's proprietary RenMiceTM platforms. As part of the agreement, Biocytogen will receive an upfront payment and will also be eligible for milestone payments during the development and commercialisation process. Additionally, Biocytogen will receive single-digit royalties on net sales. The licence agreement between Biocytogen and Pheon represents a significant expansion of Pheon's pipeline and will contribute to their ability to develop the next generation of ADCs (antibody-drug conjugates). The combination of strengths between fully human antibody discovery and ADC (Antibody-Drug Conjugate) technologies has the potential to greatly accelerate the development of new medicines that can benefit patients. RenMiceTM platforms offer a unique approach by completely replacing the variable genes of human antibodies in situ. RenMiceTM platforms has the ability to generate antibodies with low immunogenicity. Immunogenicity refers to the potential of an antibody to elicit an immune response in the body, which can reduce its effectiveness and lead to unwanted side effects.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!